French pharmaceutical company Sanofi will increase its stockpile of drugs in the UK to ensure it has a reliable supply , in case of disruption caused by a hard Brexit . Hugo Fry , managing director , Sanofi UK , said the decision was taken following recommendations from the European Federation of Pharmaceutical Industries and Associations , and Sanofi 's own assessments , and had informed Health Secretary Matt Hancock . Fry said he was confident the patients ' medicine supply would not be disrupted . Last month, AstraZeneca said it was increasing drug stockpiles by about 20% in preparation for a no-deal Brexit. In June , AstraZeneca said it was increasing stocks by 50 % in case of a hard Brexit .
French pharmaceutical company Sanofi will increase its stockpile of drugs in the UK to ensure it has a reliable supply , in case of disruption caused by a hard Brexit . Hugo Fry , managing director , Sanofi UK , said the decision was taken following recommendations from the European Federation of Pharmaceutical Industries and Associations , and Sanofi 's own assessments , and had informed Health Secretary Matt Hancock . Fry said he was confident the patients ' medicine supply would not be disrupted . In June , AstraZeneca said it was increasing stocks by 50 % in case of a hard Brexit .